Design Therapeutics, Inc.
NASDAQ:DSGN
4.96 (USD) • At close March 12, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 22.563 | 21.2 | 26.5 | 298.569 | 2.379 | 0.077 |
| Short Term Investments
| 222.914 | 260.598 | 303.887 | 85.495 | 33.712 | 0 |
| Cash and Short Term Investments
| 245.477 | 281.798 | 330.387 | 384.064 | 36.091 | 0.077 |
| Net Receivables
| 0 | 1.432 | 1.115 | 0.11 | 0.01 | 0 |
| Inventory
| 0 | 0 | -1.115 | 1.254 | 0.107 | 0 |
| Other Current Assets
| 2.563 | 1.354 | 8.349 | 1.261 | 0.132 | 0.005 |
| Total Current Assets
| 248.04 | 284.584 | 335.119 | 385.435 | 36.233 | 0.09 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 3.626 | 4.629 | 5.559 | 5.122 | 0.071 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.427 | 0.43 | 0.459 | 0 | 0.212 | 0 |
| Total Non-Current Assets
| 4.053 | 5.059 | 6.018 | 5.122 | 0.283 | 0 |
| Total Assets
| 252.093 | 289.643 | 341.137 | 390.557 | 36.516 | 0.09 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 2.186 | 1.94 | 3.025 | 1.62 | 1.399 | 2.479 |
| Short Term Debt
| 0 | 0.716 | 0.64 | 0.489 | 0 | 0.695 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0.201 |
| Other Current Liabilities
| 6.276 | 6.966 | 7.111 | 3.174 | 0.931 | 0.356 |
| Total Current Liabilities
| 8.462 | 9.622 | 10.776 | 5.283 | 2.33 | 3.731 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 1.534 | 2.334 | 6.102 | 6.288 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | -3.051 | -3.144 | 45.501 | 0.001 |
| Total Non-Current Liabilities
| 1.534 | 2.334 | 3.051 | 3.144 | 45.501 | 0.001 |
| Total Liabilities
| 9.996 | 11.956 | 13.827 | 8.427 | 47.831 | 3.732 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 390.557 | 45.356 | 0 |
| Common Stock
| 0.006 | 0.006 | 0.006 | 0.006 | 0.001 | 0.001 |
| Retained Earnings
| -227.214 | -177.626 | -110.764 | -47.456 | -11.923 | -3.643 |
| Accumulated Other Comprehensive Income/Loss
| 0.475 | 0.062 | -3.356 | -0.244 | 0.156 | 0 |
| Other Total Stockholders Equity
| 468.83 | 455.245 | 441.424 | 429.824 | -44.905 | 0 |
| Total Shareholders Equity
| 242.097 | 277.687 | 327.31 | 382.13 | -11.315 | -3.642 |
| Total Equity
| 242.097 | 277.687 | 327.31 | 382.13 | -11.315 | -3.642 |
| Total Liabilities & Shareholders Equity
| 252.093 | 289.643 | 341.137 | 390.557 | 36.516 | 0.09 |